Savant Capital, LLC Kura Oncology, Inc. Transaction History
Savant Capital, LLC
- $13.2 Billion
- Q1 2025
A detailed history of Savant Capital, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 50,524 shares of KURA stock, worth $300,617. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,524Holding current value
$300,617% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KURA
# of Institutions
189Shares Held
78.6MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$46.1 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$44.3 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$41.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$39.1 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$29.4 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $398M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...